An Evaluation of the FreeStyle Libre Flash Glucose Monitoring System
A Medium-term Evaluation of the Use, the Identified Problems, the Usability and the Effect on the Metabolic Control of the FreeStyle Flash Libre Glucose Monitoring System
1 other identifier
interventional
90
1 country
1
Brief Summary
Medium-term (6-12 months) evaluation of the use, the identified problems, the usability and the effect on the metabolic control of the FreeStyle Flash Libre glucose monitoring system in 90 children by questionnaires and routine measurement of HbA1c values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 6, 2017
CompletedStudy Start
First participant enrolled
March 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2018
CompletedJanuary 23, 2018
February 1, 2017
1 year
March 1, 2017
January 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Usability of the FreeStyle Flash Libre glucose monitoring system
Usability of the FreeStyle Flash Libre glucose monitoring system by a questionnaire
6-12 months follow up
Secondary Outcomes (2)
Problems associated with the FreeStyle Flash Libre glucose monitoring system
6-12 months follow up
The effect of the FreeStyle Flash Libre glucose monitoring system on the metabolic control in patients
6-12 months follow up
Study Arms (1)
cases
OTHERchildren (4-18 years) with type 1 diabetes mellitis using the FreeStyle Flash Libre glucose monitoring system (standard care)
Interventions
Eligibility Criteria
You may qualify if:
- Type 1 diabetes mellitis
- Being followed in the Pediatric Diabetes Unit of the Jessa Hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa Hospital
Hasselt, 3500, Belgium
Study Officials
- STUDY DIRECTOR
Guy Massa, MD, PhD
Department of Pediatric Diabetology, Jessa Ziekenhuis, Stadsomvaart 11, B3500
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2017
First Posted
March 6, 2017
Study Start
March 10, 2017
Primary Completion
March 10, 2018
Study Completion
March 10, 2018
Last Updated
January 23, 2018
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share